The Arizona Legislature today recognized April 6 as Arizona Diabetic Peripheral Neuropathy (DPN) Awareness Day, mirroring the national month of foot health awareness established by the American Podiatric Medical Association.
Evincii, a Silicon Valley based innovator in search technology, today announced "Shop to Lose," the second offering from its PICKKA line of mobile applications for health and wellness. Over 200 million Americans are overweight or obese. Shop to Lose addresses a vital part of healthy weight loss management: Guiding consumers to buy the right food products and prevent them from making unhealthy food choices.
A Kansas State University researcher is exploring the use of Chinese wolfberries to improve vision deficiencies that are common for type-2 diabetics.
Novo Nordisk, a global healthcare company and leader in diabetes care, today announced the launch of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection, treatment and care.
Diabetes Care published online the results of the Novo Nordisk (NVO) LEADTM 6 extension study, which evaluated the efficacy and safety of switching from exenatide, which is taken twice a day, to once-daily Victoza®. Results show that when added to oral antidiabetes drugs (OADs), patients who switched from exenatide to Victoza experienced further reductions in A1c and weight loss.
Undergoing surgical cancer treatment holds greater risk for people who also have diabetes than it does for people who just have cancer, according to a study being published this month in Diabetes Care.
Diabetes Research & Education Advocates of Michigan (D.R.E.A.M.) has launched its first major fundraising campaign to help discover a cure for diabetes. As part of its mission to fund research and educational projects to find a cure for diabetes, D.R.E.A.M. is raising $100,000 to go towards diabetes research at the University of Michigan C.S. Mott Children's Hospital.
Though some professional organizations recommend routine screening for type 2 diabetes, research now confirms it not only helps prevent or delay illness, it is also highly cost effective, according to a study commissioned by the American Diabetes Association being published today in the journal Lancet.
Pediatric researchers analyzing DNA variations in type 1 diabetes and inflammatory bowel disease have found a complex interplay of genes. Some genes have opposing effects, raising the risk of one disease while protecting against the other. In other cases, a gene variant may act in the same direction, raising the risk for both diseases.
The American Diabetes Association issues the following statement on the health reform bill passing in the U.S. House of Representatives today.